Patient description: 19 yo Hispanic female G1P1 at 32+ 6 weeks of gestational age presented to the OB clinic for routine follow up complaining of mild headache and leg swelling. Primary evaluation revealed BP of 146/99 and urine dipstick with 3+ proteins. Her BP and U/A were normal in previous visit. Repeat BP a few hours later is 150/100 mmHg. Laboratory studies showed a normal hematocrit, platelet count, and liver transaminase levels. She is complaining of fatigue but no fever or chills. She is also suffering of headaches with no vision changes. No shortness of breath, cough, chest pain, orthopnea and palpitations or skin rash were observed. Her physical exam was negative for abdominal pain, change in bowel habits, nausea, vomiting, dysuria, frequency, hematuria or frothy urine. Leg swelling was observed with no arthralgia or back pain. She has no specific past medical issues and only uses prenatal vitamins. Her family history is positive for DM type 2 and HTN. She is a social alcohol consumer with the negative history of smoking or drug use. She is only have one partner in past 2 years and didn't have any contraceptive methods since 2 years ago. Her BMI was 24 at the first

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pregnancy Related Cesarean Wound Disruption Cesarean Section; Infection Pregnant female age great than 18 years 2. Singleton gestation 3. Plan for cesarean delivery 4. Planned gestational age of at least weeks at the time of delivery 5. English speaking 6. Able to provide own informed consent 7. Intention of being available for entire study period and complete all relevant study procedures, including follow-up study visits and phone calls  at screening/enrollment: 1. Diabetes requiring therapy (type I or type II diabetes, gestational diabetes on medical therapy) 2. BMI greater than or equal to 40 kg/m2 at the time of enrollment 3. Placenta previa or placenta accreta 4. Prior bowel or urologic surgery (except un-ruptured appendectomy or uncomplicated cholecystectomy) 5. Multiple gestation 6. Previous history of postpartum hemorrhage requiring medical or surgical treatment 7. Known or suspected impairment of immunologic function including infection with HIV, hepatitis B or C 8. Known tobacco or drug use 9. Any condition which, in the opinion of the investigator, may pose a health risk to the subject or interfere with the evaluation of the study objectives 10. History of keloid formation at time of surgery: 1. Labor at time of presentation to labor and delivery (regular, painful uterine contractions occurring every 5 minutes with evidence of cervical change) 2. Chorioamnionitis or other systemic infection at time of presentation for cesarean section, including evidence of lower abdominal skin infection (i.e. yeast, etc) 3. Need for urgent Cesarean section (examples but not limited to: non-reassuring fetal status (category II or III tracing), placental abruption, severe preeclampsia or eclampsia) 4. Rupture of membranes prior to the start of the surgery 5. Meconium-stained or blood-stained amniotic fluid 6. Experiences intraoperative hemorrhage requiring transfusion, disseminated-intravascular coagulopathy (DIC), or other medical or surgical condition during the delivery deemed by the investigator to pose a prohibitively high risk for surgical re-exploration or wound complication. 7. Who, in the investigator's opinion, would have any clinically significant condition that would impair the patient's ability to comply with the study procedures 8. Need for vertical skin incision 9. Intraoperative use of hemostatic agent (examples and 10. Plan for use of staples at closure of the skin incision 11. Preeclampsia with severe features